legal-news
2:25-cv-02254 MERCK SHARP & DOHME B.V. et al v. XIROMED PHARMA ESPAA, S.L. et al
25-cv-02254
|
|
Filed
Advertisement
description
Case Summary
This entry duplicates the Merck Sharp & Dohme B.V. et al v. Xiromed Pharma Espaa, S.L. et al case, noting the addition of pro hac vice counsel. No further substantive information is available.
Stage
Active litigation
Timeline
1 event
Coverage
1 article
Sources
1
Key Issues
- • Pro hac vice counsel admission
- • Pharmaceutical litigation
- • Procedural development
Advertisement
Case Timeline
1 event
info
Other
April 13, 2026
2:25-cv-02254 MERCK SHARP & DOHME B.V. et al v. XIROMED PHARMA ESPAA, S.L. et al
In the case between Merck Sharp & Dohme B.V. and Xiromed Pharma España, S.L., a new lawyer who is not licensed in the state but has been granted permission to participate in this case has been added to the legal team. This allows the lawyer to represent their client in court despite not being locally licensed. It matters because it can bring specialized legal expertise to the case and affect the legal strategy.
Advertisement
newspaper
1 article